Print

ANRS VAC 16

A phase I vaccine trial evaluating the safety and immunogenicity of HIV lipopeptides by two administration routes (intramuscular and intradermal) in healthy adult volunteers

Trial Details:

I Completed
French National Agency for Research on AIDS and viral hepatitis (ANRS) July 01, 2004
LPHIV1 gag, pol-rt, pol and nef
LPHIV1 Protein
France 70
NCT00121121
http://www.clinicaltrials.gov/ct/gui/show/NCT00121121